Clinica
US FDA invites feedback on IOM advice to scrap 510(k) process
02 August 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- IOM report recommends abandoning US FDA 510(k) process in favour of new framework; industry concerned
- Medtech companies urge US FDA to enhance, not replace, 510(k) process
- US FDA proposes to streamline de novo medical device review pathway
- US FDA clarifies which device modifications will need a new 510(k) submission
Other Informa News
EVENTS
